API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.pharmacompass.com/pdf/news/anvisa-approves-cabometyx-capazantinib-levomalate-for-advanced-or-metastatic-kidney-cancer-1540289804.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-contraceptive-drug-in-the-us-market/articleshow/65560450.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205947
http://www.business-standard.com/article/companies/lupin-gets-usfda-nod-for-contraceptive-tablet-tydemy-for-women-118031300647_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205948